Sanara MedTech (SMTI) Cash from Operations (2010 - 2026)

Sanara MedTech (SMTI) has 16 years of Cash from Operations data on file, last reported at 2465407.0 in Q1 2026.

• Quarterly Cash from Operations fell 23.34% year-over-year to 2465407.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6320106.0 (up 1575.63% YoY) and the FY2025 annual result came in at 6786629.0, up 28634.43% from the prior year.
• Cash from Operations slipped to 2465407.0 in Q1 2026, from 3945061.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 3945061.0 in Q4 2025 to a low of 2465407.0 in Q1 2026.
• A 5-year average of 264881.65 and a median of 1154317.0 in 2022 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2022 — Cash from Operations plunged 245.3% — and 2025, when it soared 323.27%.
• Tracing SMTI's Cash from Operations over 5 years: stood at 645016.0 in 2022, then plunged by 31.55% to 848532.0 in 2023, then surged by 209.84% to 932047.0 in 2024, then soared by 323.27% to 3945061.0 in 2025, then tumbled by 162.49% to 2465407.0 in 2026.
• The last three Cash from Operations figures came in at 2465407.0 (Q1 2026), 3945061.0 (Q4 2025), and 2176441.0 (Q3 2025), per Business Quant data.